https://www.selleckchem.com/pr....oducts/rucaparib.htm
The in vitro antioxidant study results showed a comparable antioxidant activity with pure PPN. The anticancer study depicted that the cell viability assay of tested PLF3C2 has significantly (p less then 0.001)) reduced the IC50 when compared with pure PPN. The study revealed that oral chitosan-coated liposomes are a promising delivery system for the PPN and can increase the therapeutic efficacy against the breast cancer cell line.Metabolites are essential intermediate products in metabolism, and metabolism dysregulation indicates diff
Curtir
Comentario
Compartilhar
